Biopharma company focused on neuropsychiatric disorders developing Deraphan, a combination therapy for Alzheimer-related agitation.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €51 M | Jan, 2026 | series-b |
Industries
Frequently Asked Questions
Where is Exciva GmbH located?
Exciva GmbH is located in Heidelberg, Germany.
What industries does Exciva GmbH operate in?
Exciva GmbH operates in the following industries: biotechnology, pharmaceuticals, life sciences, healthcare.
When was Exciva GmbH founded?
Exciva GmbH was founded on 2026-01-21.
How much total funding has Exciva GmbH raised?
Exciva GmbH has raised a total of $51,000,000.
Who are the investors in Exciva GmbH?
The investors in Exciva GmbH are: Gimv, EQT Life Sciences, Andera Partners, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi VC, LBBW.
Who are the founders of Exciva GmbH?
The founders of Exciva GmbH are: Dr. Anton Bespalov, Dr. Hans Moebius, Dr. Rao Vepachedu, François Conquet.
What is the primary therapeutic focus of Exciva GmbH?
The company is a clinical-stage biopharmaceutical firm dedicated to developing novel therapies for neuropsychiatric and behavioral symptoms, such as agitation and aggression, in patients with Alzheimer's disease.
Where is the headquarters of Exciva GmbH located?
The company is based in Heidelberg, Germany, which serves as a major hub for biotechnology and clinical research.
What is the lead clinical candidate being developed by Exciva GmbH?
Their lead candidate is Deraphan, also known as EXV-802, which is a combination therapy designed to address behavioral symptoms in dementia patients.
How does the lead treatment from Exciva GmbH work?
It utilizes a synergistic combination of two compounds that act on the central nervous system to provide symptom relief without affecting the dopaminergic system, thereby minimizing side effects often seen with traditional treatments.
Who are some of the key investors supporting Exciva GmbH?
The company is backed by a syndicate of European venture capital firms, including EQT Life Sciences, Gimv, Andera Partners, and LBBW Venture Capital.